Arbet-Engels Christophe

Insider profile

Arbet-Engels Christophe's trades of X4 Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
462.48
Quantity 55,202
Value US$2,969,330
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-01-27 2025-01-24 PlS Planned sale
2,301 +1.2%
238.14
US$1,184,028
2,301 +1.2% 238.14 US$1,184,028
2025-01-24 2025-01-24 PrS Proposed sale
55,202
462.48
US$2,969,330
55,202 462.48 US$2,969,330